1.

Comparing national infectious disease surveillance systems: China and the Netherlands

2.

Comparing national infectious disease surveillance systems: China and the Netherlands

1.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

2.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

3.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

4.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

5.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

6.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

7.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

8.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

9.

Nation-wide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008.

1.

Influenza types and patient population.

2.

Influenza types and patient population.

3.

Influenza types and patient population.

4.

Influenza types and patient population.

1.

Molluscum contagiosum in Dutch general practice

2.

Molluscum contagiosum in Dutch general practice

3.

Molluscum contagiosum in Dutch general practice

4.

Molluscum contagiosum in Dutch general practice

5.

Molluscum contagiosum in Dutch general practice

6.

Molluscum contagiosum in Dutch general practice

7.

Molluscum contagiosum in Dutch general practice

8.

Molluscum contagiosum in Dutch general practice

9.

Molluscum contagiosum in Dutch general practice

1.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

2.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

3.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

4.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

5.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

6.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

7.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

8.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

9.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

1.

Increasing incidence of Barrett's oesophagus in the general population

2.

Increasing incidence of Barrett's oesophagus in the general population

3.

Increasing incidence of Barrett's oesophagus in the general population

4.

Increasing incidence of Barrett's oesophagus in the general population

1.

The association between two windchill indices and daily mortality variation in The Netherlands

1.

Epidemiology of unintentional injuries in childhood: a population-based survey in general practice

2.

Epidemiology of unintentional injuries in childhood: a population-based survey in general practice

3.

Epidemiology of unintentional injuries in childhood: a population-based survey in general practice

4.

Epidemiology of unintentional injuries in childhood: a population-based survey in general practice

1.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

2.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

3.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

4.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

5.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

6.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

7.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

8.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

9.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

1.

Laboratory-based surveillance in the molecular era:the TYPENED model, a joint data-sharing platform for clinical and public health laboratories

2.

Laboratory-based surveillance in the molecular era:the TYPENED model, a joint data-sharing platform for clinical and public health laboratories

3.

Laboratory-based surveillance in the molecular era:the TYPENED model, a joint data-sharing platform for clinical and public health laboratories

4.

Laboratory-based surveillance in the molecular era:the TYPENED model, a joint data-sharing platform for clinical and public health laboratories